Overview
Status
Active
Registry date
2023-02-28
Share capital
200 000,00 PLN
Registered address
ul. Powstańców 70, 47-220 Kędzierzyn-Koźle, Poland
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 1.35mMedianUSD 873.84kAverageUSD 20.03m
Net profit
This companyUSD 57.93kMedianUSD 28.21kAverageUSD 815.54k
Operating costs
This companyUSD 1.19mMedianUSD 801.08kAverageUSD 18.78m
Assets
This companyUSD 647.22kMedianUSD 539.29kAverageUSD 10.66m
Industry
Bank accounts
Registered as a VAT taxpayer on 2023-03-20. Active
18 1050 1979 1000 0090 8209 0581
19 1600 1462 1771 2839 0000 0002
22 1050 1764 1000 0090 8324 4559
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Anne Helene Martinet Durocher — Management Board Member
Antoine Bon — Management Board Member
Briac Le Lous — Management Board Member
Nathalie Chauvy — Management Board Member
Ewa Maria Roziel — Management Board Member
Manner of representation
Each member of the management board is independently authorised to represent the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 100 | $54,024.85 | 100% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Briac Michael Le Lous (49) | Osoba fizyczna sprawująca pośrednią kontrolę nad mybestpharm dystrybucja spółka z ograniczoną odpowiedzialnością jako właściciel udziałów w spółkach grupy urgo - łącznie 32,98% | |
Guirec Le Lous (38) | Osoba fizyczna sprawująca pośrednią kontrolę nad mybestpharm dystrybucja spółka z ograniczoną odpowiedzialnością jako właściciel udziałów w spółkach grupy urgo - łącznie 32,98% | |
Tristan Yann Christophe Le Lous (47) | Osoba fizyczna sprawująca pośrednią kontrolę nad mybestpharm dystrybucja spółka z ograniczoną odpowiedzialnością jako właściciel udziałów w spółkach grupy urgo - łącznie 32,98% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Novicaresp. z o.o. | $1,512,398.66 | novicare.pl | ||
| CryoprofilS.A. | $1,470,469.25 | cryoprofil.pl | ||
| Medimessp. z o.o. | $1,228,073.80 | medimes.pl | ||
| Optimed Pro-Office Cirrosp. j. | $1,276,876.90 | cirro.pl | ||
| Sonomedical Pluciński, Wojciechowski, Wituskisp. j. | $1,264,523.63 | sonomedical.pl | ||
| Medpipesp. z o.o. | $1,191,948.44 | medpipe.pl | ||
| Cytogen - Polskasp. z o.o. | $1,127,200.51 | cytogen.com.pl | ||
| Zbadajsiesp. z o.o. | $1,112,372.08 | labhome.pl | ||
| Salpromedisp. z o.o. | $336,017.79 | salpromedi.pl | ||
| Przedsiębiorstwo Handlowo Usługowe Weton Wyszyński i Wspólnicysp. j. | — | weton.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-05-14 | PKD change (Removed: 47.19.Z, 47.29.Z, 47.75, 47.91.Z, 85; Added: 47.27.Z, 47.74.Z, 47.75.Z, 47.78.Z, 85.59.D) | |
| 2023-02-28 | Entered in the register |
FAQ
The main business activity of Mybestpharm Dystrybucja focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on February 28, 2023.
The headquarters is located at: ul. Powstańców 70, 47-220 Kędzierzyn-Koźle.
The management board includes Ewa Maria Roziel (Member of the Management Board).
The share capital of the company is PLN 200,000 (approx. $54,025).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $1,347,390 in 2025, which is a decrease of 19.9% compared to 2024.
Yes, in 2025 the company was profitable, achieving a net profit of $57,931, meaning the company decreased its profit by 77.8%.
The largest operating cost category falls under employee remuneration. This category amounted to $423,795 in 2025, representing 36% of all operating expenses.
Last updated: 2026-04-28
